✦ LIBER ✦

S21 Chemoprevention of breast cancer: The Italian experience with retinoids and low-dose tamoxifen

✍ Scribed by A. Decensi; D. Marra; A. Guerrieri Gonzaga; B. Bonanni

Book ID: 119601740
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 38 KB
Volume: 8
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(10)70757-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemoprevention of breast cancer: The It

Chemoprevention of breast cancer: The Italian experience

✍ Andrea Decensi; Bernardo Bonanni; Aliana Guerrieri-Gonzaga; Rosalba Torrisi; Lap 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

The activity of our group is focused on the conduction of chemoprevention clinical trials of breast cancer in at-risk subjects, among which we include women on hormone replacement therapy (HRT). The role of the insulin-like growth factor (IGF) system and of mammographic breast density as surrogate b

Session 6 Primary prevention of breast c

Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S16. Is low-dose tamoxifen a reasonable alternative?

✍ Andrea Decensi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 122 KB

S18 Chemoprevention of breast cancer by

S18 Chemoprevention of breast cancer by tamoxifen and raloxifene: the US-experience in NSABP-prevention trials

✍ V. Vogel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

S20 Chemoprevention of breast cancer: Th

S20 Chemoprevention of breast cancer: The European and Australian IBIS and other trial experience with aromatase inhibitors

✍ J. Forbes 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Session 6 Primary prevention of breast c

Session 6 Primary prevention of breast cancer II: Update of chemoprevention with tamoxifen, raloxifen and aromatase-inhibitors: S17. Aromatase inhibitors in breast cancer prevention: The IBIS-II trial

✍ J. Cuzick 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 36 KB

P40 The HOT study: Hormone replacement t

P40 The HOT study: Hormone replacement therapy opposed by low dose of tamoxifen. A phase III trial of breast cancer prevention with low dose tamoxifen in HRT users: Background and rationale of the project

✍ M.C. Varricchio; B. Bonanni; A. Decensi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 119 KB